AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Category : Search result: AstraZeneca
Enhertu Breakthrough in Early Breast Cancer Treatment
Groundbreaking research reveals Enhertu significantly reduces recurrence risk in HER2-positive early breast cancer patients, marking a potential turning point in oncology care.
Page 1 of 1